Global Vitamin B12 Series API 麻豆原创 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR082415597

Publication Date:

August 26, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Vitamin B12 series APIs are a group of pharmaceutical grade cobalt compounds, namely cobalamin, including cyanocobalamin, adenosylcobalamin, hydroxocobalamin and methylcobalamin. Vitamin B12 can be divided into pharmaceutical grade, food grade and feed grade. Vitamin B12 derivatives are generally pharmaceutical grade and used in medicines, including adenosylcobalamin, hydroxocobalamin and methylcobalamin.
The global Vitamin B12 Series API market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Vitamin B12 Series API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Vitamin B12 Series API market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2019-2030
Global Vitamin B12 Series API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2019-2030
Global Vitamin B12 Series API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2019-2030
Global Vitamin B12 Series API market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vitamin B12 Series API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vitamin B12 Series API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include EUROAPI, Eisai Co., Ltd, HTBA, Cspc Holdings Company, Ningxia Kingvit Pharmaceutical, Yufeng Industry Group, North China Pharmaceutical Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Vitamin B12 Series API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Cyanocobalamin
Methylcobalamin
Adenosylcobalamin
Hydroxocobalamin
麻豆原创 segment by Application
Oral Formulation
Injectable Formulation
Sprays
Major players covered
EUROAPI
Eisai Co., Ltd
HTBA
Cspc Holdings Company
Ningxia Kingvit Pharmaceutical
Yufeng Industry Group
North China Pharmaceutical Company
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vitamin B12 Series API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vitamin B12 Series API, with price, sales quantity, revenue, and global market share of Vitamin B12 Series API from 2019 to 2024.
Chapter 3, the Vitamin B12 Series API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vitamin B12 Series API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Vitamin B12 Series API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vitamin B12 Series API.
Chapter 14 and 15, to describe Vitamin B12 Series API sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Vitamin B12 Series API Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Cyanocobalamin
1.3.3 Methylcobalamin
1.3.4 Adenosylcobalamin
1.3.5 Hydroxocobalamin
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Vitamin B12 Series API Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oral Formulation
1.4.3 Injectable Formulation
1.4.4 Sprays
1.5 Global Vitamin B12 Series API 麻豆原创 Size & Forecast
1.5.1 Global Vitamin B12 Series API Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Vitamin B12 Series API Sales Quantity (2019-2030)
1.5.3 Global Vitamin B12 Series API Average Price (2019-2030)
2 Manufacturers Profiles
2.1 EUROAPI
2.1.1 EUROAPI Details
2.1.2 EUROAPI Major Business
2.1.3 EUROAPI Vitamin B12 Series API Product and Services
2.1.4 EUROAPI Vitamin B12 Series API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 EUROAPI Recent Developments/Updates
2.2 Eisai Co., Ltd
2.2.1 Eisai Co., Ltd Details
2.2.2 Eisai Co., Ltd Major Business
2.2.3 Eisai Co., Ltd Vitamin B12 Series API Product and Services
2.2.4 Eisai Co., Ltd Vitamin B12 Series API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Eisai Co., Ltd Recent Developments/Updates
2.3 HTBA
2.3.1 HTBA Details
2.3.2 HTBA Major Business
2.3.3 HTBA Vitamin B12 Series API Product and Services
2.3.4 HTBA Vitamin B12 Series API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 HTBA Recent Developments/Updates
2.4 Cspc Holdings Company
2.4.1 Cspc Holdings Company Details
2.4.2 Cspc Holdings Company Major Business
2.4.3 Cspc Holdings Company Vitamin B12 Series API Product and Services
2.4.4 Cspc Holdings Company Vitamin B12 Series API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Cspc Holdings Company Recent Developments/Updates
2.5 Ningxia Kingvit Pharmaceutical
2.5.1 Ningxia Kingvit Pharmaceutical Details
2.5.2 Ningxia Kingvit Pharmaceutical Major Business
2.5.3 Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Product and Services
2.5.4 Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Ningxia Kingvit Pharmaceutical Recent Developments/Updates
2.6 Yufeng Industry Group
2.6.1 Yufeng Industry Group Details
2.6.2 Yufeng Industry Group Major Business
2.6.3 Yufeng Industry Group Vitamin B12 Series API Product and Services
2.6.4 Yufeng Industry Group Vitamin B12 Series API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Yufeng Industry Group Recent Developments/Updates
2.7 North China Pharmaceutical Company
2.7.1 North China Pharmaceutical Company Details
2.7.2 North China Pharmaceutical Company Major Business
2.7.3 North China Pharmaceutical Company Vitamin B12 Series API Product and Services
2.7.4 North China Pharmaceutical Company Vitamin B12 Series API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 North China Pharmaceutical Company Recent Developments/Updates
3 Competitive Environment: Vitamin B12 Series API by Manufacturer
3.1 Global Vitamin B12 Series API Sales Quantity by Manufacturer (2019-2024)
3.2 Global Vitamin B12 Series API Revenue by Manufacturer (2019-2024)
3.3 Global Vitamin B12 Series API Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Vitamin B12 Series API by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Vitamin B12 Series API Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Vitamin B12 Series API Manufacturer 麻豆原创 Share in 2023
3.5 Vitamin B12 Series API 麻豆原创: Overall Company Footprint Analysis
3.5.1 Vitamin B12 Series API 麻豆原创: Region Footprint
3.5.2 Vitamin B12 Series API 麻豆原创: Company Product Type Footprint
3.5.3 Vitamin B12 Series API 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Vitamin B12 Series API 麻豆原创 Size by Region
4.1.1 Global Vitamin B12 Series API Sales Quantity by Region (2019-2030)
4.1.2 Global Vitamin B12 Series API Consumption Value by Region (2019-2030)
4.1.3 Global Vitamin B12 Series API Average Price by Region (2019-2030)
4.2 North America Vitamin B12 Series API Consumption Value (2019-2030)
4.3 Europe Vitamin B12 Series API Consumption Value (2019-2030)
4.4 Asia-Pacific Vitamin B12 Series API Consumption Value (2019-2030)
4.5 South America Vitamin B12 Series API Consumption Value (2019-2030)
4.6 Middle East & Africa Vitamin B12 Series API Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Vitamin B12 Series API Sales Quantity by Type (2019-2030)
5.2 Global Vitamin B12 Series API Consumption Value by Type (2019-2030)
5.3 Global Vitamin B12 Series API Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Vitamin B12 Series API Sales Quantity by Application (2019-2030)
6.2 Global Vitamin B12 Series API Consumption Value by Application (2019-2030)
6.3 Global Vitamin B12 Series API Average Price by Application (2019-2030)
7 North America
7.1 North America Vitamin B12 Series API Sales Quantity by Type (2019-2030)
7.2 North America Vitamin B12 Series API Sales Quantity by Application (2019-2030)
7.3 North America Vitamin B12 Series API 麻豆原创 Size by Country
7.3.1 North America Vitamin B12 Series API Sales Quantity by Country (2019-2030)
7.3.2 North America Vitamin B12 Series API Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Vitamin B12 Series API Sales Quantity by Type (2019-2030)
8.2 Europe Vitamin B12 Series API Sales Quantity by Application (2019-2030)
8.3 Europe Vitamin B12 Series API 麻豆原创 Size by Country
8.3.1 Europe Vitamin B12 Series API Sales Quantity by Country (2019-2030)
8.3.2 Europe Vitamin B12 Series API Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Vitamin B12 Series API Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Vitamin B12 Series API Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Vitamin B12 Series API 麻豆原创 Size by Region
9.3.1 Asia-Pacific Vitamin B12 Series API Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Vitamin B12 Series API Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Vitamin B12 Series API Sales Quantity by Type (2019-2030)
10.2 South America Vitamin B12 Series API Sales Quantity by Application (2019-2030)
10.3 South America Vitamin B12 Series API 麻豆原创 Size by Country
10.3.1 South America Vitamin B12 Series API Sales Quantity by Country (2019-2030)
10.3.2 South America Vitamin B12 Series API Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Vitamin B12 Series API Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Vitamin B12 Series API Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Vitamin B12 Series API 麻豆原创 Size by Country
11.3.1 Middle East & Africa Vitamin B12 Series API Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Vitamin B12 Series API Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Vitamin B12 Series API 麻豆原创 Drivers
12.2 Vitamin B12 Series API 麻豆原创 Restraints
12.3 Vitamin B12 Series API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Vitamin B12 Series API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vitamin B12 Series API
13.3 Vitamin B12 Series API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vitamin B12 Series API Typical Distributors
14.3 Vitamin B12 Series API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

EUROAPI
Eisai Co., Ltd
HTBA
Cspc Holdings Company
Ningxia Kingvit Pharmaceutical
Yufeng Industry Group
North China Pharmaceutical Company

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.